Andere Sprachen Orient EuroPharma Co., Ltd.

Aktien

4120

TW0004120001

4120

Schlusskurs Taipei Exchange Andere Börsenplätze 00:00:00 28.06.2024			% 5 Tage	% 1. Jan.
46.25 ^TWD	+4.40%		+6.81%	+18.89%

20.05.	Orient Europharma Co., Ltd. unterzeichnet eine exklusive Vertriebs- und Marketingvereinbarung für das neue AIDS-Medikament Trogarzo in Taiwan mit Taimed Biologics	CI
15.05.	Orient EuroPharma Co., Ltd. meldet Ergebnis für das erste Quartal bis zum 31. März 2024	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Orient Europharma Co., Ltd. Signs an Exclusive Sales and Marketing Agreement for the New AIDS Drug Trogarzo in Taiwan with Taimed Biologics	20.05.
Orient EuroPharma Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	15.05.
Regeneus Ltd announced that it expects to receive AUD 3.481164 million in funding from Zheng Yang Biomedical Technology Co., Ltd., Orient EuroPharma Co., Ltd. and other investors	05.04.
Orient EuroPharma Co., Ltd. announced that it expects to receive TWD 300 million in funding	29.03.
Orient EuroPharma Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	01.03.
Orient EuroPharma Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	09.11.
Orient EuroPharma Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	11.08.23
Orient EuroPharma Co., Ltd. Appoints Jack Wang as Accounting Officer	10.08.23
Orient EuroPharma Co., Ltd. Appoints Jack Wang as Financial Officer	01.08.23
Orient EuroPharma Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	12.05.23
Orient EuroPharma, OncoVent Sign License Deal	30.03.23
OncoVent Enters into a License and Distribution Agreement with Orient EuroPharma for the Immunotherapeutic Candidate Oregovomab	28.03.23
Orient EuroPharma Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	07.03.23
Orient EuroPharma Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	07.03.23
Orient EuroPharma Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	11.11.22
Orient EuroPharma Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	09.08.22
Orient EuroPharma Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	14.05.22
Orient EuroPharma Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	25.02.22
Orient EuroPharma Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	11.11.21
Orient Europharma Co., Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2021	12.08.21

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Orient EuroPharma Co., Ltd.

Aktien

4120

TW0004120001

4120

Andere Sprachen

Filter